VALINK THERAPEUTICS
Live / Registered — Registered (as of 15 Apr 2025)
What this means for you
Registered since 15 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79397608
- Registration number
- 7757032
- Mark type
- Stylized text
- Filed
- 05 Mar 2024
- Published for opposition
- 25 Feb 2025
- Registered
- 15 Apr 2025
- Attorney of record
- Matthew A. Homyk
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science; biological preparations for use in industry and science; proteins for use in science; proteins for use in industry; proteins for detecting antibodies, other than for medical use; proteins for binding antibodies, other than for medical use; immunological antibodies, other than for medical use; chemical substances for use in the biotechnological industry; chemicals for use in the pharmaceutical industry; chemical substances for use in the production of drugs; chemicals for use in scientific research, other than medical or veterinary; chemicals for use in biotechnological product development
- Class 005 — Pharmaceuticals: Pharmaceuticals, medical and veterinary preparations for the prevention and treatment of cancer in humans and animals; pharmaceutical drugs for the prevention and treatment of cancer in humans and animals; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer drugs; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; chemotherapeutics; biotechnological preparations for medical use for the treatment of cancer; antibodies for medical purposes
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto in the fields of pharmaceutical, biomedical, and chemical sciences; biotechnology research; biological research; clinical research in the field of radiology and chemotherapy; medical research; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; research and development in the pharmaceutical and biotechnology fields; biotechnology testing; scientific research relating to biotechnology; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemical research services of biochemistry drugs; biochemistry consultancy; biochemistry research services; biochemical research and development; research and development in the field of biotechnology; biochemical engineering services; scientific laboratory services; biochemical research laboratory services; medical research laboratory services; medical research laboratories; providing information relating to scientific research in the fields of biochemistry and biotechnology; consultancy in the field of pharmaceutical research; scientific consultancy in the field of biotechnology; consultancy relating to research and development in the field of therapeutics
Owner
- Valink Therapeutics Inc., US
- Valink Therapeutics Inc., DE, US
- Valink Therapeutics Inc., DE, US
- Valink Therapeutics Inc., DE, US
Prosecution history
- 30 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 22 Nov 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 12 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 05 Nov 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 04 Nov 2025 — FINAL DISPOSITION PROCESSED
- 16 Jul 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 04 Jul 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 16 May 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 15 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2025 — PUBLISHED FOR OPPOSITION
- 19 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER